Change in the number of votes relating to Biotie Therapies Corp.'s shares


BIOTIE THERAPIES CORP.                  Stock Exchange Release            16
March 2015 at 9.00 am

Change in the number of votes relating to Biotie Therapies Corp.'s shares

Biotie Therapies Corp. ("Biotie" or the "Company") has conveyed Biotie shares
held as treasury shares, that were issued on 17 December 2014, pursuant to the
Equity Incentive Plan 2011 (the "Plan") as follows:

 Shares conveyed Cumulative shares conveyed      Remaining shares to be
                 since                           conveyed
                 17 December  2014

  300,000        1,576,875                       870,500

The second vesting period of the Equity Incentive Plan 2011 ended on 5 January
2015, after which the Company's shares shall be delivered to employees on the
basis of the granted share units. It was resolved pursuant to the authorization
of the Annual General Meeting of the Shareholders held on 3 April 2014 to issue
300,000 existing treasury shares to the employees without consideration for the
purposes of remunerating the employees pursuant to the terms and conditions of
the Equity Incentive Plan 2011 and thus, there is an especially weighty
financial reason to derogate from the pre-emptive right of the shareholders, as
referred to in Chapter 9 Section 4(1) of the Companies Act (624/2006, as
amended). Due to share issues already made pursuant to the Equity Incentive Plan
2011, forfeitures and some of the instruments based on the plan having been left
unallocated, a maximum of 945,000 shares may still be issued pursuant to the
Equity Incentive Plan 2011.

The conveyed shares previously held as treasury shares have not carried any
voting rights. The conveyance does not affect the number of registered shares.
After the conveyances the changes are as follows:

 Increase in number of      Total amount of Number of the         Total number
 outstanding shares         voting rights   Company's shares held of registered
                                            by the Group          shares

 300,000                    452,272,890     3,695,284             455,968,174




Turku, 16 March 2015

Biotie Therapies Corp.

Timo Veromaa, President and CEO

For further information, please contact:
Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp.
tel. +358 2 274 8900, e-mail: virve.nurmi@biotie.com

www.biotie.com

DISTRIBUTION:
NASDAQ OMX Helsinki Ltd
Main Media




[HUG#1903667]